Pupillometry in Horner's Syndrome

Sponsor
University of Zurich (Other)
Overall Status
Recruiting
CT.gov ID
NCT02978079
Collaborator
(none)
135
1
1
70.5
1.9

Study Details

Study Description

Brief Summary

Horner's syndrome (HS) is a result of interruption of the sympathetic innervation to the eye and ocular adnexa, which can occur due to carotid artery dissection (CAD), along which the sympathetic nerve fibers travel to reach the eye. Dissection of the carotid artery is one of the etiologies for ischemic stroke in young patients.

In our current study, we will explore the diagnostic accuracy of automated binocular pupillometry in the diagnosis or HS, and its potential in identifying dissection of the carotid artery in patients of young age who suffer ischemic stroke.

Condition or Disease Intervention/Treatment Phase
  • Device: Automated pupillometry
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
135 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Automated Pupillometry for the Diagnosis of Horner's Syndrome in Acute Stroke Patients Due to Carotid Artery Dissection
Actual Study Start Date :
Feb 15, 2017
Anticipated Primary Completion Date :
Dec 31, 2021
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Pupillometry in stroke patients

All eligible patients will undergo pupillometry test for the finding of Horner's syndrome

Device: Automated pupillometry
Automated pupillometry will be performed in patients with acute stroke with the intention of diagnosing Horner's syndrome

Outcome Measures

Primary Outcome Measures

  1. Finding of pupillary dilation lag using pupillometry in patients with acute stroke due to carotid artery dissection [1 day of initial visit]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults 60 years of age or younger

  • Acute stroke (less than 72 hours from admission)

  • Informed Consent as documented by signature (Appendix Informed Consent Form)

  • Ability to understand the study information and consent form

Exclusion Criteria:
  • known history of HS

  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

  • Medications affecting pupillary response

  • History of ocular surgery affecting the pupil

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ophthalmology Department, University Hospital Zurich Zurich Switzerland CH-8091

Sponsors and Collaborators

  • University of Zurich

Investigators

  • Principal Investigator: Konrad P Weber, MD, Ophthalmology Department, University Hospital Zurich

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Konrad Peter Weber, Principal Investigator, University of Zurich
ClinicalTrials.gov Identifier:
NCT02978079
Other Study ID Numbers:
  • KEK-Nr. 2016-02151
First Posted:
Nov 30, 2016
Last Update Posted:
Jan 11, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 11, 2021